Product Information
MEXILETINE 250 MG CAPSULE is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.4464 per EA under NDC 50742024101. Its NADAC has been published 217 times since Jun 2, 2021.
Strength
250 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742024101
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MEXILETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214352On Market Since
1/26/2021
Pharmacological Classes
Price Statistics
The NADAC for MEXILETINE 250 MG CAPSULE has been published 217 times since Jun 2, 2021, and over the history we have for it it has declined 70.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4464 per EA |
|---|---|
| All-time high | $1.4878 (Jan 12, 2022) |
| All-time low | $0.4101 (Nov 19, 2025) |
| 52-week high | $0.4943 |
| 52-week low | $0.4101 |
| Median price | $0.4900 |
| Average price | $0.8008 |
| Largest weekly change | -57.2% (Apr 17, 2024) |
| Weeks tracked | 217 |
| Tracking since | Jun 2, 2021 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MEXILETINE 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MEXILETINE 250 MG CAPSULE, manufactured by Ingenus Pharmaceuticals LLC, is $0.4464 per EA (NDC 50742024101), effective Jun 24, 2026.
How has the price of MEXILETINE 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MEXILETINE 250 MG CAPSULE has declined 70.0%. It has been tracked across 217 weekly CMS publications since Jun 2, 2021.
What are the highest and lowest recorded NADAC prices for MEXILETINE 250 MG CAPSULE?
Since Jun 2, 2021, the NADAC for MEXILETINE 250 MG CAPSULE has ranged from a low of $0.4101 (Nov 19, 2025) to a high of $1.4878 (Jan 12, 2022), with a median of $0.4900 per EA.
Are there cheaper alternatives to MEXILETINE 250 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as MEXILETINE 250 MG CAPSULE, but none are currently priced below it.
Who manufactures MEXILETINE 250 MG CAPSULE?
MEXILETINE 250 MG CAPSULE (NDC 50742024101) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification